While some would argue that Amazon (NASDAQ:AMZN) has three moneymakers with e-commerce, AWS and its digital advertising business if AMZN…

Read more

Stoke Therapeutics Inc STOK shares are rising in Tuesday’s after-hours session, riding a wave a momentum higher despite announcing a…

Read more

Wednesday, Japan approved AstraZeneca Plc AZN and Sanofi SA’s SNY Beyfortus (nirsevimab), a long-acting monoclonal antibody for the prophylaxis of lower respiratory tract disease (LRTD)…

Read more

Monday, Axsome Therapeutics Inc AXSM released data from the SYMPHONY Phase 3 trial of AXS-12 (reboxetine) in narcolepsy patients. Narcolepsy is a sleep…

Read more

Flora Growth Corp. FLGC shares are trading higher Monday, and the stock is up more than 35% over the past…

Read more

Friday, the FDA granted emergency use authorization to Invivyd Inc’s IVVD Pemgarda (pemivibart), formerly VYD222, a half-life extended monoclonal antibody (mAb) for…

Read more

Tilray Brands, Inc. TLRY and Canopy Growth Corporation CGC shares are trading higher Monday with renewed optimism on the possible…

Read more

Wednesday, IGC Pharma Inc IGC announced the results of an interim analysis of its ongoing Phase 2 trial of IGC-AD1 for Agitation…

Read more

Friday, Geron Corporation’s GERN shares are trading lower with a high session volume of 5.82 million compared to the average 100-day volume…

Read more

Geron Corp GERN shares are soaring in Thursday’s after-hours session after the company announced that the U.S. Food and Drug Administration’s…

Read more